Nanomaterials and synergistic low-intensity direct current (LIDC) stimulation technology for orthopedic implantable medical devices

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 5, Issue 3, 2013, Pages 191-204

  Shirwaiker, Rohan A ^a,b   Samberg, Meghan E ^b,c   Cohen, Paul H ^a   Wysk, Richard A ^a,b   Monteiro Riviere, Nancy A ^b,c,d  

^a North Carolina State University   (United States)

^b USA and North Carolina State University   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL EFFICACY; BIOMEDICAL RESEARCH; CLINICAL APPLICATION; DIRECT ELECTRIC CURRENTS; ENGINEERING TECHNIQUES; IMPLANTABLE MEDICAL DEVICES; NATURALLY OCCURRING; TISSUE ENGINEERING SCAFFOLD;

ELECTRIC PROPERTIES; IMPLANTS (SURGICAL); NANOSTRUCTURED MATERIALS; REPAIR; SCAFFOLDS (BIOLOGY); SYNTHETIC METALS; TISSUE;

BIOMEDICAL EQUIPMENT;

METAL; NANOCOATING; NANOCOMPOSITE; NANOMATERIAL; POLYMER; SILVER NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; BONE REGENERATION; CERAMICS; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DIRECT CURRENT; ELECTROSTIMULATION; FRACTURE; HUMAN; IONIZATION; LOW INTENSITY DIRECT CURRENT; MARKETING; MEDICAL DEVICE COMPLICATION; ORTHOPEDIC IMPLANT; OSTEOARTHRITIS; OSTEOMYELITIS; PRIORITY JOURNAL; RELIABILITY; REVIEW; SURFACE PROPERTY; SURGICAL INFECTION; TISSUE ADHESION; TISSUE GROWTH; TISSUE IMPLANT; TISSUE REGENERATION;

ANIMALS; ELECTRIC STIMULATION; EQUIPMENT AND SUPPLIES; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; ORTHOPEDICS; PROSTHESES AND IMPLANTS;

EID: 84876463086     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1201     Document Type: Review

References (149)

1. Korkin A, Gusev E, Labanowski JK, Luryi S, eds. Nanotechnology for Electronic Materials and Devices. New York, NY: Springer; 2007, 368.
2. Nalwa HS, ed. Nanomaterials for Energy Storage Applications. Valencia, CA: American Scientific Publishers; 2009, 350.
3. Gouma P. Nanomaterials for Chemical Sensors and Biotechnology. Singapore: Pan Stanford Publishing; 2010, 159.
4. Growth Opportunities in Global Nanomaterials Market 2011-2016: Trend, Forecast, and Opportunity Analysis. Dallas, TX: Lucintel (Global Market Research Firm); 2011, 153.
5. Saji SV, Choe HC, Yeung KWK. Nanotechnology in biomedical applications: a review. Int J Nano Biomaterials 2010, 3:119-139.
6. Roszek B, de Jong WH, Geertsma RE, Nanotechnology in medical applications: state-of-the-art in materials and devices. Netherlands: Department of Pharmaceutical Affairs and Medical Technology of the Dutch Ministry of Health, Welfare and Sports; 2005, 123. Report no. 265001001/2005.
7. Implantable Medical Devices: Industry Study with Forecasts for 2015 and 2020, 2012. Cleveland, OH: The Fredonia Group; 2012, 395.
8. Tran N, Webster TJ. Nanotechnology for bone materials. WIREs Nanomed Nanobiotechnol 2009, 1:336-351.
9. Thomas JB, Peppas NA, Sato M, Webster TJ. Nanotechnology and biomaterials. In: Gogotsi Y, ed. Nanomaterials Handbook. 1st ed. Boca raton, FL: CRC Press; 2006, 605-634.
10. Christenson EM, Anseth KS, van den Beucken JJJP, Chan CK, Ercan B, Jansen JA, Laurencin CT, Li WJ, Murugan R, Nair LS, et al. Nanobiomaterial applications in orthopedics. J Orthop Res 2007, 25:11-22.
11. Fuller T, Wysk RA, Charumani C, Kennett M, Sebastiennelli WJ, Abrahams RA, Shirwaiker RA, Voigt RC, Royer P. Developing an engineered antimicrobial/prophylactic system using electrically activated bactericidal metals. J Mater Sci Mater Med 2010, 21:2103-2114.
12. Xie L, Jacobson JM, Choi ES, Busa B, Donahue LR, Miller LM, Rubin CT, Judex S. Low-level mechanicalvibrations can influence bone resorption and bone formation in the growing skeleton. Bone 2006, 39:1059-1066.
13. Fini M, Cadossi R, Canè V, Cavani F, Giavaresi G, Krajewski A, Martini L, Aldini NN, Ravaglioli A, Rimondini L, et al. The effect of pulsed electromagnetic fields on the osteointegration of hydroxyapatite implants in cancellous bone: a morphologic and microstructural in vivo study. J Orthop Res 2002, 20:756-763.
14. Sharifi S, Behzadi S, Laurent S, Forrest ML, Stroeve P, Mahmoudi M. Toxicity of nanomaterials. Chem Soc Rev 2012, 41:2323-2343.
15. Orthopedic Implants-A Global Market Overview. Hyderabad, India: Industry Experts; 2011, 197.
16. Khang D, Lu J, Yao C, Haberstroh KM, Webster TJ. The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomater 2008, 29:970-983.
17. Ballo A, Agheli H, Lausmaa J, Thomsen P, Petronis S. Nanostructured model implants for in vivo studies: influence of well-defined nanotopography on de novo bone formation on titanium implants. Int J Nanomed 2011, 6:3415-3428.
18. Gao L, Feng B, Wang J, Lu X, Liu D, Qu S, Weng J. Micro/nanostructural porous surface on titanium and bioactivity. J Biomed Mater Res Part B Appl Biomater 2008, 89:335-341.
19. Van der Borden AJ, van der Werf H, van der Mei C, Busscher HJ. Electric current-induced detachment of Staphylococcus epidermidis biofilms from surgical stainless steel. Appl Environ Microbiol 2004, 70:6871-6874.
20. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals Ti, Ti6Al4V, and CoCrMo. Biomaterials 2004, 25:4731-4739.
21. Han P, Ji W, Zhao C, Zhang X, Jiang Y. Improved osteoblast proliferation, differentiation and mineralization on nanophase Ti6Al4V. Chinese Med J 2011, 124:273-279.
22. Juan L, Zhimin Z, Anchun M, Lei L, Jingchao Z. Deposition of silver nanoparticles on titanium surface for antibacterial effect. Int J Nanomedicine 2010, 5:261-267.
23. Albers CE, Hofstetter W, Siebenrock KA, Landmann R, Klenke FM. In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicol 2011: 1-7 (Epub ahead of print).
24. Streicher RM, Schmidt M, Fiorito S. Nanosurfaces and nanostructures for artificial orthopedic implants. Nanomedicine 2007, 2:861-874.
25. Thapa A, Miller DC, Webster TJ, Haberstroh KM. Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials 2003, 24:2915-2926.
26. 2 electrode surface on cell response and electrochemical stability in artificial saliva. Bioelectrochemistry 2010, 79:122-129.
27. Ergun C, Liu H, Webster TJ, Olcay E, Yilmaz S, Sahin FC. Increased osteoblast adhesion on nanoparticulate calcium phosphates with higher Ca/P ratios. J Biomed Mater Res 2008, 85A:236-241.
28. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 2004, 54:1019-1024.
29. Samberg ME, Orndorff PE, Monteiro-Riviere NA. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 2011, 5:244-253.
30. Pinto RJB, Fernandes SCM, Freire CSR, Sadocco P, Causio J, Neto CP, Trindade T. Antibacterial activity of optically transparent nanocomposite films based on chitosan or its derivatives and silver nanoparticles. Carbohydrate Res 2012, 348:77-83.
31. 2 nano-structured thin film with a silver hierarchical configuration. Appl Surf Sci 2008, 254:1630-1635.
32. Balasundaram G, Webster TJ. A perspective on nanophase materials for orthopedic implant applications. J Mater Chem 2006, 16:3737-3745.
33. Makhluf S, Dror R, Nitzan Y, Abramovich Y, Jelinek R, Gedanken A. Microwave-assisted synthesis of nanocrystalline MgO and its use as a bacteriocide. Adv Funct Mater 2005, 15:1708-1715.
34. Price RL, Ellison K, Haberstroh KM, Webster TJ. Nanometer surface roughness increases select osteoblast adhesion on carbon nanofiber compacts. J Biomed Mater Res A 2004, 70:129-138.
35. Webster TJ, Waid MC, McKenzie JL, Price RL, Ejiofor JU. Nano-biotechnology: carbon nanofibres as improved neural and orthopaedic implants. Nanotechnology 2004, 15:48-54.
36. Shao S, Zhou S, Li L, Li J, Luo C, Wang J, Li X, Weng J. Osteoblast function on electrically conductive electrospun PLA/MWCNTs nanofibers. Biomaterials 2011, 32:2821-2833.
37. Kasuga T. Formation of titanium oxide nanotubes using chemical treatments and their characteristic properties. Thin Solid Films 2006, 496:141-145.
38. Popat KC, Leoni L, Grimes CA, Desai TA. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials 2007, 28:3188-3197.
39. Singh MK, Marques PAAP, Sousa ACM, Gracio J, Silva VS, Goncalves PP, Ferreira JMF, Olhero S. Biotoxicity study of bone cement based on a functionalised multi-walled carbon nanotube-reinforced PMMA/HAp nanocomposite. Int J Nano Biomater 2009, 2:442-453.
40. Das K, Bose S, Bandyopadhyay A. Titanium surface modification to titania nanotube for next generation orthopedic applications. In: Narayan R, Colombo P, eds. Advances in Bioceramics and Porous Ceramics: Ceramic Engineering and Science Proceedings. Hoboken, NJ: John Wiley & Sons; 2009, 29:7.
41. Swami N, Cui Z, Nair L. Titania nanotubes: novel nanostructures for improved osseointegration. J Heat Transfer 2011, 034002-1-7:133.
42. Zhan GD, Kuntz JD, Wan J, Mukherjee AK. Singlewalled carbon nanotubes as attractive toughening agents in alumina based nanocomposites. Nat Mater 2003, 2:38-42.
43. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng 2001, 7:291-301.
44. Webster TJ, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 2000, 21:1803-1810.
45. Catledge SA, Fries MD, Vohra YK, Lacefield WR, Lemons JE, Woodard S, Venugopalan R. Nanostructured ceramics for biomedical implants. J Nanosci Nanotechnol 2002, 2:293-312.
46. Klein CP, Patka P, van der Lubbe HB, Wolke JG, de Groot K. Plasma-sprayed coatings of tetracalciumphosphate, hydroxylapatite and α-TCP on titanium allow: an interface study. J Biomed Mater Res 1991, 25:53-65.
47. Chen Y, Zhang YQ, Gan CH, Yu G. Wear studies of hydroxyapatite composite coating reinforced by carbon nanotubes. Carbon 2007, 45:998-1004.
48. Shokuhfar T, Titus E, Cabral G, Sousa ACM, Gracio J, Ahmed W, Okpalugo T, Makradi A, Ahzi S. Modelling on the mechanical properties of nanocomposite hydroxyapatite/PMMA/carbon nanotube coatings. Int J Nano Biomater 2007, 1:107-115.
49. Werner P, Altstaed V, Jaskulka R, Jacobs O, Sandler JKW, Shaffer MSP, Windle AH. Tribological behaviour of carbon-nanofibre-reinforced poly(ether ether ketone). Wear 2004, 257:1006-1014.
50. Thapa A, Webster TJ, Haberstroh KM. Polymers with nano-dimensional surface features enhance bladder smooth muscle cell adhesion. J Biomed Mater Res A 2003, 67A:1374-1383.
51. Johanson PE, Digas G, Herberts P, Thanner J, Karrholm J. Highly crosslinked polyethylene does not reduce aseptic loosening in cemented THA 10-year findings of a randomized study. Clin Orthop Relat Res 2012, 470:3083-3093.
52. Bahraminasab M, Sahari BB, Edwards KL, Farahmand F, Arumugam M, Hong TS. Aseptic loosening of femoral components-a review of current and future trends in materials used. Mater Des 2012, 42:459-470.
53. Wang W, Ouyang Y, Poh CK. Orthopaedic implant technology: biomaterials from past to future. Ann Acad Med Singapore 2011, 40:237-244.
54. American Academy of Orthopaedic Surgeons (AAOS), 2005. Available at: http://www.aaos.org/. (Accessed August 6, 2012).
55. Mann S. Biomineralization: Principles and Concepts in Bioinorganic Materials Chemistry. Oxford: Oxford University Press; 2002, 210.
56. Einhorn T.A, O'Keefe RJ, Buckwalter JA, eds. Orthopaedic Basic Science. 3rd ed. Rosemont, IL: American Academy of Orthopaedic Surgeons (AAOS); 2007, 465.
57. Balasundaram G, Webster TJ. Nanotechnology and biomaterials for orthopaedic medical applications. Nanomedicine 2006, 1:169-176.
58. Dalby MJ, Riehle MO, Johnstone H, Affrossman S, Curtis ASG. In vitro reaction of endothelial cells to polymer demixed nanotopography. Biomaterials 2002, 23:2945-2954.
59. Dalby MJ, Childs S, Riehle MO, Johnstone H, Affrossman S, Curtis ASG. Fibroblast reaction to island topography: changes in cytoskeleton and morphology with time. Biomaterials 2003, 24:927-935.
60. Chehroudi B, McDonnell D, Brunette DM. The effects of micromachined surfaces on formation of bonelike tissue on subcutaneous implants as assessed by radiography and computer image processing. J Biomed Mater Res 1997, 34:279-290.
61. Cochran DL, Buser D. ten Bruggenkate CM, Weingart D, Taylor TM, Bernard JP, Peters F, Simpson JP. The use of reduced healing times on ITI implants with a sandblasted and acidetched (SLA) surface: early results from clinical trials on ITI SLA implants. Clin Oral Implants Res 2002, 13:144-153.
62. Papalexiou V, Novaes AB, Jr., Grisi MFM, Souza SSLS, Taba M, Jr., Kajiwara JK. Influence of implant microstructure on the dynamics of bone healing around immediate implants placed into periodontally infected sites: a confocal laser scanning microscopic study. Clin Oral Implants Res 2004, 15:44-53.
63. Daugaard H, Elmengaard B, Bechtold JE, Soballe K. The effect of dual acid texturing implants on bone ongrowth-an unloaded implant model in an experimental canine study. Trans 52nd Orth Res Soc Meeting, 2006, 948.
64. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004, 32:477-486.
65. Anderson JM, Gristina AG, Hanson SR. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. Biomaterial Science: An Introduction to Materials in Medicine. San Diego, CA: Academic Press; 1996, 165-214.
66. Besim BN, Choi AH. Sol-gel production of bioactive nanocoatings for medical applications. Part 1: an introduction. Nanomedicine 2006, 1:311-319.
67. Balani K, Anderson R, Laha T, Andara M, Tercero J, Crumpler E, Agarwal A. Plasma-sprayed carbon nanotube reinforced hydroxyapatite coatings and their interaction with human osteoblasts in vitro. Biomaterials 2007, 28:618-624.
68. Davies JE. The importance of surface charge species in cell behaviour at the biomaterial interface. In: Ratner BD, ed. Surface Characteristics of Biomaterials. New York, NY: Elsevier; 1988.
69. Webster TJ. Nanophase ceramics: the future of orthopedic and dental implant material. In: Ying JY, ed. Nanostructured Materials. New York, NY: Academy Press; 2001, 125-166.
70. Simchi A, Tamjid E, Pishbin F, Boccaccini AR. Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomed Nanotech Biol Med 2011, 7:22-39.
71. Sculco TP. Economic impact of infected total joint arthroplasty. Instr Course Lect 1993, 42:349-351.
72. Garvin KL, Hanssen AD. Infection after total hip arthroplasty. Past present, and future. J Bone Joint Surg Am 1995, 77:1576-1588.
73. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 1999, 48:111-122.
74. Gosheger G. Antimicrobial coating. Abstract symposium-prevention and treatment of infection in orthopaedic surgery, 2003.
75. Williams H, Griffiths P. The effectiveness of pin site care for patients with external fixators. Br J Community Nurs 2004, 9:206-221.
76. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987, 237:1588-1595.
77. Montanaro L, Testoni F, Poggi A, Visai L, Speziale P, Arciola CR. Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus. Int J Artif Organs 2011, 34:781-788.
78. Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant material. Biomater 2012, 33:5967-5982.
79. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004, 350:1422-1429.
80. Ehrlich GD, Stoodley P, Kathju S, Zhao Y, McLeod BR, Balaban N, Hu FZ, Sotereanos NG, Costerton JW, Stewart PS, et al. Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res 2005, 437:59-66.
81. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomised clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995, 98:349-356.
82. Walder B, Pittet D, Tramer MR. Prevention of bloodstream infections with central venous catheters treated with antiinfective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 2002, 23:748-756.
83. Crabtree JH, Burchette RJ, Siddiqi RA. The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections. Perit Dial Int 2003, 23:368-374.
84. Madhumathi K, Sudheesh Kumar PT, Abhilash S, Sreeja V, Tamura H. Development of novel chitin/nanosilver composite scaffolds for wound dressing applications. J Mater Sci Mater Med 2010, 21:807-813.
85. Travan A, Marsich E, Donati I, Paoletti S. Silver nanocomposites and their biomedical applications. In: Kumar CSSR, ed. Nanocomposites. Germany: Wiley-VCH; 2010, 81-127.
86. Lago VD, de Oliveira LF, Goncalves KA, Kobarg J, Cardoso MB. Size-selective silver nanoparticles: future of biomedical devices with enhanced bactericidal properties. J Mater Chem 2011, 21:12267-12273.
87. Nanda A, Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomed Nanotech Biol Med 2009, 5:452-456.
88. Elechiguerra J, Burt J, Morones J, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 2005, 3:6.
89. Kim J, Kuk E, Yu K, Kim J, Park JS, Lee HJ, Kim SH, Park YK, Park YH. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol 2007, 3:95-101.
90. Lu L, Sun R, Chen R, Hui C, Ho C, Luk JM, Lau GKK, Che C-M. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 2008, 13:253-262.
91. Arumugam SK, Sastry TP, Sreedhar SB, Mandal AS. One step synthesis of silver nanorods by autoreduction of aqueous silver ions with hydroxyapatite: an inorganic-inorganic hybrid nanocomposite. J Biomed Mater Res 2007, 80:391-398.
92. Min Y, Akulut M, Kristairsen K, Golan Y, Israelachvili J. The role of interparticle and external forces in nanoparticle assembly. Nat Mater 2008, 7:527-538.
93. Wagener M, Biogate AG. Silver based nanocomposites for antimicrobial medical devices. Proc Nano Europe 2006, 9:12-14.
94. Chang YY, Huang HL, Chen YC, Weng JC, Lai CH. Characterization and antibacterial performance of ZrNO-Ag coatings. Surf Coat Tech 2012. Available at: http://dx.doi.org/10.1016/j.surfcoat.2012.05.084. (Accessed May 30, 2012).
95. Bignozzi CA, Carinci F, Caramori S, Dissette V. 2008. Nanomaterial coatings for osteointegrated biomedical prosthesis PCT Int Appl WO 2008020460.
96. Kang S, Pinault M, Pfefferle LD, Elimelech M. Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir 2007, 23:8670-8673.
97. Kang S, Herzberg M, Rodrigues DF, Elimelech M. Antibacterial effects of carbon nanotubes: size does matter! Langmuir 2008, 24:6409-6413.
98. Smart SK, Cassady AI, Lu GQ, Martin DJ. The biocompatibility of carbon nanotubes. Carbon 2006, 44:1034-1047.
99. Taylor E, Webster TJ. Reducing infections through nanotechnology and nanoparticles. Int J Nanomed 2011, 6:1463-1473.
100. Schierholz JM, Rump AF, Pulverer G, Beuth J. Anti-infective catheters: novel strategies to prevent nosocomial infections in oncology. Anticancer Res 1998, 18:3629-3638.
101. Singh AV, Vyas V, Patil R, Sharma V, Scopelliti PS, Bongiorno G, Podesta A, Lenardi C, Gade WN, Milani P. Quantitative characterization of the influence of the nanoscale morphology of nanostructured surfaces on bacterial adhesion and biofilm formation. PLoS One 2011, 6:e25029.
102. 2. J Biomed Mater Res Part A 2006, 78A:595-604.
103. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009, 27:76-83.
104. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res A 2000, 52:662-668.
105. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface 2007, 275:177-182.
106. Morones JR, Elechiguerra JL, Camacho A, Ramirez JT. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
107. Song HY, Ko KK, Oh LH, Lee BT. Fabrication of silver nanoparticles and their antimicrobial mechanisms. Eur Cells Mater 2006, 11:58.
108. Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicol 2010, 4:319-330.
109. Zhao J, Castranova V. Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B 2011, 14:593-632.
110. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 2010, 118:407-413.
111. Sinha N, Yeow JTW. Carbon nanotubes for biomedical applications. IEEE Trans Nanobiosci 2005, 4:180-195.
112. Sirivisoot S, Pareta R, Webster TJ. Electrically controlled drug release from nanostructured polypyrrole coated on titanium. Nanotechnology 2011, 22:085101.
113. Eberson CP, Hogan K, Moore D, Ehrlich MG. Effect of low-intensity ultrasound stimulation on consolidation of the regenerate zone in a rat model of distraction osteogenesis. J Ped Orthop 2003, 23:46-51.
114. Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res 2004, 19:360-369.
115. Barranco SD, Spadaro JD, Berger TJ, Becker RO. In vitro effect of weak direct current on Staphylococcus aureus. Clin Orthop 1974, 100:250-255.
116. Berger TJ, Spadaro JA, Chapin SE, Becker RO. Electrically generated silver ions: quantitative effects on bacterial and mammalian cells. Antimicrob Agents Chemother 1976, 9:357-358.
117. Becker RO, Spadaro JA. Treatment of orthopedic infections with electrically generated silver ions. J Bone Joint Surg 1978, 60:871-881.
118. Wysk RA, Sebastianelli WJ, Shirwaiker RA, Bailey GM, Charumani C, Kennett M, Kaucher A, Abrahams R, Fuller TA, Royer P, et al. Prophylactic bactericidal orthopedic implants-animal testing study. J Biomed Sci Eng 2010, 3:917-926.
119. Shirwaiker RA, Wysk RA, Kariyawasam S, Carrion H, Voigt RC. Micro-scale fabrication and characterization of a silver-polymer based electrically activated antibacterial surface. Biofabrication 2011, 3:015003.
120. Mader JT, Nordern C, Nelson JD, Calandra GB. Evaluation of new anti-infective drugs for the treatment of osteomyelitis in adults. Clin Infect Dis 1992, 15(Suppl 1):S155-S161.
121. Slawson RM, Vandyke MI, Lee H, Trevors JT. Germanium and silver resistance, accumulation, and toxicity in microorganisms. Plasmid 1992, 27:72-77.
122. Burrell R, Heggers J, Wright J. Efficacy of silver coated dressings as bacterial barriers in a rodent burn sepsis model. Wounds 1999, 11:64-71.
123. Stobie N, Duffy B, Hinder SJ, McHale P, McCormack DE. Silver doped perfluoropolyether-urethane coatings: antibacterial activity and surface analysis. Colloids Surf 2009, 72:62-67.
124. Gardner SE, Frantz RA, Schmidt FL. Effect of electrical stimulation on chronic wound healing: a meta-analysis. Wound Repair Regen 1999, 7:495-503.
125. Kloth LC, Feedar JA. Acceleration of wound-healing with high-voltage, monophasic, pulsed current. Phys Ther 1988, 68:503-508.
126. Feedar JA, Kloth LC, Gentzkow GD. Chronic dermal ulcer healing enhanced with monophasic pulsed electrical stimulation. Phys Ther 1991, 71:639-649.
127. Lundeberg TCM, Eriksson SV, Malm M. Electrical nerve stimulation improves healing of diabetic ulcers. Ann Plast Surg 1992, 29:328-331.
128. Baker LL, Chambers R, DeMuth SK, Villar F. Effects of electrical stimulation on wound healing in patients with diabetic ulcers. Diabetes Care 1997, 20:405-412.
129. Wellman N, Fortun SM, McLeod BR. Bacterial biofilms and the bioelectric effect. Antimicrob Agents Chemother 2006, 40:2012-2014.
130. Del Pozo JL, Rouse MS, Mandrekar JN, Steckelberg JM, Patel R. The electricidal effect: reduction of staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical current. Antimicrob Agents Chemother 2009, 53:41-45.
131. Yonemori K, Matsunaga S, Ishidou Y, Maeda TS, Yoshida H. Early effects of electrical stimulation on osteogenesis. Bone 1996, 19:173-180.
132. Yarington CT, Jaquiss GW. Electrical control of bone growth in ossicles. Arch Otolaryngol 1969, 89:856-860.
133. Korenstein R, Somjen D, Fischler H, Binderman I. Capacitative pulsed electric stimulation of bone cells. Induction of cyclic-AMP and DNA synthesis. Biochem Biophys Acta 1984, 803:302-307.
134. Friedenberg ZB, Zerasky LM, Pollis RP. The response of non-tranmatized bone to direct current. J Bone Jt Surg 1974, 56A:1023-1030.
135. Lavine LS, Lustrin I, Shamos MH, Moss ML. The influence of electric current on bone regeneration in vivo. Acta Orthop Scand 1971, 42:305-314.
136. Uysal T, Amasyali M, Olmez H, Karslioglu Y. Stimulation of bone formation by direct electrical current in an orthopedically expanded suture in the rat. Korean J Orthod 2010, 40:106-114.
137. Brighton CT, Black J, Friedenberg ZB, Esterhai JL, Day LJ, Connolly JF. A multicenter study of the treatment of non-union with constant direct current. J Bone Joint Surg Am 1981, 63:2-13.
138. Ercan B, Webster TJ. The effect of biphasic electrical stimulation on osteoblast function at anodized nanotubular titanium surfaces. Biomaterials 2010, 31:3684-3693.
139. Le Gu'ehennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater 2007, 23: 844-854.
140. Wong M, Eulenberger J, Schenk R, Hunziker E. Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res 1995, 29:1567-1575.
141. Becker W, Becker BE, Ricci A, Bahat O, Rosenberg E, Rose LF, Handelsman M, Israelson H. A prospective multicentre clinical trial comparing one- and two-stage titanium screwshaped fixtures with one-stage plasma-sprayed solid-screw fixtures. Clin Implant Dent Relat Res 2000, 2:159-165.
142. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
143. Auffan M, Rose J, Bottero JV, Lowry GV, Jolivet JP, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol 2009, 4: 634-641.
144. Ramires PA, Romito A, Cosentino F, Milella E. The influence of titania/hydroxyapatite composite coatings on in vitro osteoblasts behaviour. Biomaterials 2001, 22:1467-1474.
145. Laurencin CT, Kumbar SG, Nukavarapu SP. Nanotechnology and orthopedics: a personal perspective. WIREs Nanomed Nanobiotechnol 2009, 1:6-10.
146. Mehta S, Parvizi J. Nanotechnology in orthopaedic surgery. US Musculoskeletal Review 2009, 4:8-10.
147. Panyala NR, Pena-Mendez EM, Havel J. Silver or silver nanoparticles: a hazardous threat to the environment and human health? J App Biomed 2008, 6:117-129.
148. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 2010, 118:407-413.
149. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 2007, 18:225103.